Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/26/2025

Clonazepam Tapering Protocols

Pharmacokinetics and Tapering

  • Clonazepam's long half-life (30-40 hours) provides some self-tapering effect, allowing for more aggressive tapering in a controlled inpatient setting 1

Withdrawal Symptom Management

  • Clonidine 0.1-0.2 mg BID/TID can be used to mitigate autonomic symptoms, such as hypertension and tachycardia, during clonazepam tapering, with close monitoring of blood pressure 2

Critical Safety Monitoring

  • Severe autonomic instability, including hypertension and tachycardia, is a life-threatening withdrawal risk requiring immediate intervention during clonazepam tapering 1

REFERENCES

1

Clonazepam's Impact on Restorative Sleep [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025